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Negative elongation factor (NELF) is known to enforce
promoter-proximal pausing of RNA polymerase II
(Pol II), a pervasive phenomenon observed across
multicellular genomes. However, the physiological
impact of NELF on tissue homeostasis remains un-
clear. Here, we show that whole-body conditional
deletion of the B subunit of NELF (NELF-B) in adult
mice results in cardiomyopathy and impaired
response to cardiac stress. Tissue-specific knockout
of NELF-B confirms its cell-autonomous function in
cardiomyocytes.NELFdirectly supports transcription
of thosegenesencoding rate-limitingenzymes in fatty
acid oxidation (FAO) and the tricarboxylic acid (TCA)
cycle. NELF also shares extensively transcriptional
target genes with peroxisome proliferator-activated
receptor a (PPARa), a master regulator of energy
metabolism in the myocardium. Mechanistically,
NELF helps stabilize the transcription initiation com-
plex at the metabolism-related genes. Our findings
strongly indicate that NELF is part of the PPARa-
mediated transcription regulatory network that main-
tains metabolic homeostasis in cardiomyocytes.
INTRODUCTION
RNA polymerase II (Pol II) is preferentially accumulated at
transcription start sites (TSSs) of a large number of genes in
multicellular organisms (Adelman and Lis, 2012; Levine, 2011).
Whereas the enrichment of Pol II density at TSS alone is not
necessarily indicative of a distinct mode of regulation, whole-
genome analysis of nascent transcripts clearly demonstrates
that Pol II indeed pauses at a position downstream of TSS after
the synthesis of short stretches of RNA (Core et al., 2008).
Furthermore, negative elongation factor (NELF) in metazoan isan important regulator of Pol II pausing (Kwak and Lis, 2013;
Yamaguchi et al., 1999). Depletion of any of the four NELF sub-
units results in disintegration of the entire complex and global
reduction of Pol II pausing. NELF-mediated Pol II pausing is
antagonized by the positive transcription elongation factor,
P-TEFb, a cyclin-dependent kinase (Zhou et al., 2012). Whereas
NELF was first identified biochemically as an inhibitor of
transcription elongation, subsequent studies indicate that
NELF-mediated Pol II pausing can lead to both decreased and
increased transcription (Adelman and Lis, 2012). The underlying
mechanism by which NELF facilitates transcription is not fully
understood. However, it has been shown that NELF-mediated
Pol II pausing can prevent the encroachment of nucleosomes
at the promoter-proximal region, suggesting that NELFmay sup-
port multiple rounds of transcription in vivo by maintaining a
nucleosome-free region at the promoter (Gilchrist et al., 2010;
Sun and Li, 2010). In contrast to the extensive in vitro studies,
there is a significant gap of knowledge concerning the physiolog-
ical roles of NELF in mammals.
Cardiomyopathy is characterized by a rigid, thick, and
enlarged heart muscle (Cahill et al., 2013). As cardiomyopathy
deteriorates, normal cardiac functions (e.g., blood pumping
and maintenance of electrical rhythm) are significantly compro-
mised due to myocyte loss and increased fibrosis. This can ulti-
mately result in heart failure, a prevalent and debilitating disease
with high morbidity and mortality. At the histological level, hearts
with cardiomyopathy manifest with infiltrating inflammatory cells
and interstitial collagen accumulation. One of the major causes
of cardiomyopathy is inefficient energy production in cardiomyo-
cytes, which results in failure tomeet the high demands of energy
consumption and compromised intracellular Ca2+ homeostasis
for contraction (Frey et al., 2012). In the normal myocardium,
cardiomyocytes alternate between carbohydrates and fatty
acids as sources of energy, with the latter contributing up to
70% of the energy requirement for an adult heart (Stanley
et al., 2005). Energy metabolism is regulated by both acute
mechanisms (e.g., allosteric controls and posttranslational mod-
ifications) and long-term transcriptional regulation that rendersCell Reports 7, 79–85, April 10, 2014 ª2014 The Authors 79
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Figure 1. NELF-B KO Leads to Cardio-
myopathy
(A) Hematoxylin and eosin staining of left ventricles
from control (Ctrl) and NELF-B knockout (KO) mice.
The scale bar represents 50 mm.
(B) Picrosirius red staining for collagen deposition.
The scale bar represents 50 mm.
(C) Quantification of picrosirius red staining (n = 5).
Here and elsewhere in the figures, *p < 0.05. Error
bars represent SEM.
(D) Quantification of cell size of over 100 individual
cardiomyocytes (n = 3).
(E) Relative mRNA levels of two hypertrophy
markers (n = 6).
(F) Representative left ventricular M-mode echo-
cardiography. The double-headed arrows indicate
the left ventricular dimension at diastole (longer
arrow) and systole (shorter arrow).
(G) Fractional shortening from the left ventricle (LV)
at rest (thin lines) and following dobutamine injection
(thick lines). Ctrl: n = 11; KO: n = 8.more sustained changes in metabolic rates. Reduced transcrip-
tion of rate-limiting enzymes involved in cardiac fatty acid meta-
bolism is often associated with heart failure, forcing the cardiac
switch to carbohydrates as the main source of energy (Hue and
Taegtmeyer, 2009).
Several members of the nuclear receptor superfamily and
their coactivators, in particular peroxisome proliferator-activated
receptors (PPARs), PPAR gamma coactivator 1 (PGC-1), and
estrogen-related receptors (ERRs), are known to play critical
roles in controlling energy-metabolism-related transcription in
cardiomyocytes (Gigue`re, 2008; Madrazo and Kelly, 2008;
Rowe et al., 2010). Impairment of the transcriptional programs
dictated by these critical regulators in humans is often associ-
ated with heart failure and myocardial ischemia (Sihag et al.,
2009). Consistent with the clinical observations, heart-specific
disruption of the mouse counterparts of these transcription
factors results in cardiac dysfunction with reduced capacity in
fatty acid oxidation (FAO) and mitochondrial ATP production
(Huss et al., 2007; Smeets et al., 2008).80 Cell Reports 7, 79–85, April 10, 2014 ª2014 The AuthorsTo elucidate the physiological role of
NELF in homeostasis of adult tissues, we
generated both whole-body and cardio-
myocyte-specific knockout (KO) mouse
models that deleted the B subunit of
mouse NELF (NELF-B). By combining
transcriptomics and metabolomics ap-
proaches, we further investigated the
underlying mechanism by which NELF
contributes to cardiac functions.
RESULTS AND DISCUSSION
Inducible NELF-B Knockout Animals
Develop Cardiomyopathy
Our previous work indicates that mouse
NELF-B is essential for early embryogen-
esis (Amleh et al., 2009). To determinethe role of NELF-B in adult tissue, we circumvented embryonic
lethality of conventional NELF-B KO by crossing the NELF-Bf/f
mice with a whole-body tamoxifen (TAM)-inducible Cre-ER
strain (Figure S1A). The resulting NELF-Bf/f,Cre-ER mice were
born with the expected Mendelian ratio. NELF-Bf/f,Cre-ER and
their control littermates were injected with TAM at 8 weeks of
age and confirmed for TAM-induced deletion of the floxed
NELF-B allele (Figure S1B). Compared to TAM-treated control
mice, NELF-Bf/f,Cre-ER mice with inducible KO of NELF-B had
a shortened life span (11 months), resulting from increased inci-
dences of sudden death with no outward signs of gross abnor-
malities. For this reason, we selected 10 months (40 weeks) as
our primary endpoint for the following histological study.
Histological analysis of KO myocardium revealed obvious
signs of cardiomyopathy accompanied by infiltrating inflamma-
tory cells including neutrophils (Figures 1A, S1C, and S1D).
This was in sharp contrast to themyocardium from age-matched
animals carrying one or two alleles of wild-type NELF-B, either
with or without Cre-ER (NELF-B+/+, Cre-ER; NELF-Bf/f; and
NELF-B+/f, Cre-ER; collectively referred to as the control group
hereafter). Immunohistochemistry confirmed efficient depletion
of NELF-B in cardiomyocytes of the KO mice (Figure S1E). In-
flammatory infiltration was observed in 100% of the KO mice
at 32 weeks after TAM-induced NELF-B deletion (40 weeks of
age). Thus, the KO mice developed the pathological phenotype
with a high penetrance and relatively early onset.
Fibrosis is often associated with cardiomyopathy, and we
therefore stained heart sections with picrosirius red for collagen
deposition. Pronounced interstitial fibrosis was observed in the
left ventricles of KO mice (Figures 1B and 1C). Because cardiac
hypertrophy is an initiating event in the development of progres-
sive heart failure, we measured myocyte cross-sectional areas.
The average individual cardiomyocyte cross-sectional area in
the KO mice was significantly larger than their control counter-
parts (Figure 1D). In addition, expression of two established
markers of cardiac hypertrophy, Nppb and Acta1, were mark-
edly elevated in the KO mice (Figure 1E). Taken together, these
results are consistent with the cardiomyopathy evaluated at
autopsy of the NELF-B KO mice.
To further assess cardiac function of the live KO animals, we
performed echocardiography of the left ventricle (LV) fromweeks
8 to 32, at 8-week intervals. We evaluated function at rest
and following pharmacologically induced cardiac stress. At the
8-week time point prior to TAM-induced NELF-B deletion, the
KO mice exhibited comparable LV function as the control
littermates (Figures 1F and 1G; Table S1). Following the TAM-
induced NELF-B deletion, the control and KO groups of mice
at rest displayed no differences for up to the 32-week time point
evaluated, indicating that NELF-B deletion did not affect LV
function under basal conditions. Dobutamine, a b1-adrenergic
agonist and cardiac-stress inducer, is used to evaluate cardiac
reserve in experimental animals and in patients who cannot ex-
ercise on a treadmill. Stress echocardiography was acquired
at 30 min after intraperitoneal injection of dobutamine. In both
control and KO mice, dobutamine treatment significantly
increased fractional shortening (FS) and decreased LV end sys-
tolic and end diastolic dimensions at all age groups measured
(Figures 1F and 1G; Table S1). This indicates that both control
and KO mice responded to dobutamine stress. However, KO
mice at week 32 demonstrated significantly lower FS compared
to the control mice treated with dobutamine, suggesting impair-
ment of cardiac reserve in KO mice. The functional cardiac
deterioration in KO mice strongly indicates an important role of
NELF-B in sustaining normal cardiac contractility under stressed
conditions.
Despite the effective depletion of NELF-B in cardiomyocytes
(Figure S1E), it remained possible that the cardiac phenotype
could be due to NELF-B deletion in other tissue/cell types.
We therefore generated a cardiomyocyte-specific inducible
knockout mouse model for NELF-B by crossing the floxed
NELF-B mice with a-myosin heavy chain promoter-driven,
inducible MerCreMer (a-MHC-MCM) transgenic mice. TAM-
induced depletion of NELF-B in cardiomyocytes of the resulting
MHC-KO animals was confirmed by genotyping and mRNA
analysis (Figures S2A and S2B). Similar to the findings of the
whole-body KO, the cardiomyocyte-specific KO mice devel-
oped prominent signs of cardiomyopathy, excessive cardiacfibrosis, and elevated expression of the hypertrophy marker
Acta1 by age of 24 weeks (Figures S2C–S2E). The mRNA
increase of Nppb, another hypertrophy marker, in the cardio-
myocyte-specific KO was not as significant as that in the
whole-body KO (compare Figures 1E and S2E). However, the
overall similarity of cardiac defects between the whole-body
and cardiomyocyte-specific KO mice strongly indicates a cell-
autonomous role of NELF-B in supporting normal myocardial
function.
NELF-B KO Reduces Energy-Metabolism-Related
Transcription in Cardiomyocytes
Next, we performed gene expression profiling of LV from three
pairs of the control and whole-body KO mice. Out of approxi-
mately 19,000 unique genes in the mouse genome evaluated,
a total of 211 and 253 genes were up- and downregulated,
respectively, 1.3-fold or more in KO samples as compared with
the control samples (Table S2; GSE54372). In line with our earlier
findings (Figure 1D), the hypertrophy marker Acta1 was at the
top of the upregulated genes in the KO mice. Normal cardio-
myocytes are adapted to high-capacity energy production
through efficient FAO and aerobic metabolism in mitochondria.
Consistent with the cardiac dysfunction in KO mice, gene
ontology indicates that the downregulated genes in LV of
KO mice are enriched with those that are involved in energy
metabolism including mitochondrial function, FAO, and the
tricarboxylic acid (TCA) cycle (data not shown). The changes in
mRNA levels of these genes were validated by gene-specific
RT-PCR (Figures 2A and 2B). In addition, nine of the ten meta-
bolism-related genes examined were also downregulated in LV
of the cardiomyocyte-specific KO mice (Figure S3A), confirming
a cell-autonomous function of NELF-B in gene regulation.
Among the metabolism-related genes affected in KO myo-
cardium, carnitine palmitoyltransferase 1b (Cpt1b) encodes the
rate-limiting enzyme in FAO that is responsible for transporting
long-chain fatty acyl-coenzyme A via the carnitine shuttle into
the mitochondrial matrix, where they are subsequently oxidized.
Isocitrate dehydrogenase 3g (Idh3g), another downregulated
gene in KO, encodes one of the rate-limiting enzymes in the
TCA cycle. Reduced protein expression of both enzymes in the
KO hearts was verified by immunoblotting (Figure S3B). To
determine whether the NELF complex acts directly on these
genes, we performed chromatin immunoprecipitation (ChIP) for
different NELF subunits using myocardium of wild-type mice.
NELF-A, -B, and -C/D were all enriched preferentially at the
TSSs of the Cpt1b and Idh3g genes as compared to a region 1
kb downstream of TSS (Figures 2C–2E), suggesting a direct
role of NELF in activation of these energy-metabolism-related
genes.
To explore the functional outcome of the reduced metabolic
gene expression in KO mice, we performed metabolomics by
high-performance liquid chromatography-electrospray ioniza-
tion-tandem mass spectrometry (HPLC-ESI-MS/MS). Consis-
tent with reduced expression of Cpt1b, the levels of various
acyl-carnitine molecules were significantly diminished in the
KO heart tissue (Figure 2F; Table S3). In addition, reduced
expression of the enzymes in the TCA cycle coincided with
accumulation of the corresponding upstream intermediates inCell Reports 7, 79–85, April 10, 2014 ª2014 The Authors 81
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B Figure 2. NELF-B Supports Energy-Meta-
bolism-Related Transcription in Cardiomyo-
cytes
(A and B) Verification of microarray results (n = 3)
for genes involved in fatty acid oxidation (FAO) and
TCA cycle.
(C–E) ChIP of NELF-A (C), NELF-B (D), and NELF-C/
NELF-D (E) at the TSS and 1 kb downstream (DS)
region of the Cpt1b and Idh3g genes in wild-type
myocardium (n = 3). IgG, immunoglobulin G.
(F and G) Diagrams of the FAO (F) and TCA cycle (G)
with indicated changes in metabolic intermediates
and enzymes in KO (red for increase and blue
decrease).the KO samples (Figure 2G; Table S3). This includes citrate
and cis-aconitate upstream of Idh3g and succinate upstream
of Sdhc. Interestingly, KO hearts also exhibited a significant in-
crease in the levels of ceramides, which have been implicated
in cardiomyopathy and cardiac failure (Table S3; Park and Gold-
berg, 2012). Thus, the combined transcriptomics and meta-
bolomics data strongly suggest that NELF supports the high
demand of energy production in cardiomyocytes through sus-
tained metabolic gene expression.
NELF Is Part of the PPARa-Dependent Transcription
Regulatory Network in Cardiomyocytes
Gene ontology analysis of the gene expression profile indicates a
significant enrichment of genes involved in the PPAR-regulated
pathways (data not shown). Among the several PPAR family
members, PPARa plays an especially important role in orches-
trating the cardiac transcription program required for high-
capacity energy production in cardiomyocytes (Gigue`re, 2008;
Madrazo and Kelly, 2008). Comparing the gene expression82 Cell Reports 7, 79–85, April 10, 2014 ª2014 The Authorsprofile of the NELF-B KO with previously
published microarray data from PPARa
KO myocardium (Georgiadi et al., 2012),
we found that these two KO mouse
models shared a substantial overlap in
downregulated target genes (p < 1 3
105; Figure 3A), 85% of which are meta-
bolism-related (Figure 3B). In contrast,
the overlap among the upregulated target
genes was statistically much less sig-
nificant (p = 0.0128; Figure 3A). A similar,
albeit weaker, correlation was also ob-
served between NELF-B and ERRa KO
(Figure S3C; Dufour et al., 2007).
The NELF-B KO myocardium did not
have reduced expression of PPARa, its
DNA-binding partner retinoid X receptor a
(RXRa), or its coactivator PGC-1a (Table
S2; Figure S3D). Furthermore, expression
of Cdk9 and cyclin T1, two components
of P-TEFb, was comparable between the
control and KO myocardium (Figure S3E).
We therefore favored the possibility that
NELF directly supports transcription of thePPARa target genes. Using a recently published PPARa ChIP
sequencing data set (Boergesen et al., 2012), we found that
36.9% of NELF-regulated genes in myocardium have PPARa
binding peak(s) within 10 kb of TSS, in comparison with 12.1%
of the genes in the entire mouse genome (Figure 3C; p = 2.2 3
1016). Moreover, ChIP confirmed chromatin association of
NELFwith the TSS region at 16out of the 17downregulatedgenes
shared by NELF-B and PPARa KO (Figure 3D). These findings
further support the notion that NELF is part of the PPARa-medi-
ated transcription regulatory circuitry in cardiomyocytes.
NELF Facilitates Occupancy of the Transcription
Initiation Complex at the Metabolism-Related
Promoters
To obtain more insight into NELF-mediated transcription, we
examined chromatin occupancy of NELF and Pol II. As ex-
pected, the TSS-associated NELF-A ChIP signals were signifi-
cantly diminished in NELF-B KO myocardium (Figure S4A),
corroborating the action of the different NELF subunits as an
DA
C
B Figure 3. NELF-B Is Part of the PPARa Tran-
scriptional Regulatory Network
(A) Overlap in down- and upregulated genes in
NELF-B and PPARa KO myocardium. The green
and red squares denote the enrichment score (ES)0
values of down- and upregulated genes, respec-
tively. The diamond-dotted curve is the frequency
distribution of ES values for sets of randomly
selected genes.
(B) Heatmap for the overlapped genes in theNELF-
B and PPARa KO mouse myocardium.
(C) Venn diagram illustrating the presence of
PPARa binding sites at the NELF target genes in
myocardium.
(D) NELF-A ChIP at the NELF-B and PPARa com-
mon target genes listed in (B) (n = 3).integrative complex in intact animal tissue. Consistent with the
reduced mRNA levels of these metabolic genes in KO myocar-
dium, the ChIP signals of total Pol II at the TSS were reduced
substantially for four of the five metabolism-related genes in
the NELF-B KO myocardium (Figure 4A). A similar observation
was made for the phosphorylated-serine 5 Pol II (Figure S4B).
We also examined Pol II intensity at gene-body regions down-
stream of TSS and calculated the ratio of TSS over gene-body
ChIP signals. Surprisingly, none of the five NELF-regulated
metabolic genes showed altered ratio in KO myocardium (Fig-
ure 4B), suggesting that NELF-B KO resulted in proportional
reduction in Pol II density at TSS and gene body of these meta-
bolic genes. In contrast, Lpl and Myl3, two NELF-associated
genes whose expression was not affected by NELF-B KO,
exhibited a preferential decrease of Pol II density at TSS in KO
(Figures S4C and S4D). Thus, the effect of NELF on mRNA
expression does not necessarily correlate with its impact on
TSS-specific Pol II density.Cell Reports 7, 7Next, we assessed promoter occupancy
of transcription initiation factors. The
KO myocardium exhibited substantially
reduced chromatin binding of the general
transcription factors TFIIB (Figure 4C) and
TFIID (TBP; Figure S4E) at the NELF-regu-
latedmetabolic genes, but not a number of
metabolism-unrelated genes whose tran-
scription was not affected by NELF-B KO
(Figure S4F). Chromatin binding of RXRa,
the PPAR DNA-binding partner (Boerge-
sen et al., 2012), was also reduced at three
of the four common target promoters for
NELF and PPARa (Figure 4D). On the other
hand, the density of histone H3, which was
used for assessing nucleosome density
(Gilchrist et al., 2010; Sun and Li, 2010;
Figure S4G), was not significantly affected
at any of the NELF-regulated promoters
in the KO myocardium (Figure 4E), sug-
gesting that the reduced chromatin occu-
pancy of the initiation factors is unlikely
due to nucleosome encroachment. Takentogether, these results indicate that NELF plays a role in facili-
tating association of transcription initiation factors with the
promoters of the metabolism-associated genes.
The NELF-B knockout animals developed in the current study
provide a genetic model for dissecting the physiological impact
of this critical Pol II-pausing factor in mammals. Importantly, our
in vivo work uncovers a role of NELF-mediated Pol II pausing in
energy-metabolism-related gene activation in cardiomyocytes.
Furthermore, our findings strongly suggest that NELF acts as
part of the PPARa-dependent regulatory network. The organ-
selective dysfunction and distinctive transcriptomics of the
NELF-B KO mice clearly point to a context-dependent role of
NELF in transcriptional regulation.
NELF-B depletion led to diminished promoter occupancy of
transcription initiation factors, indicating that NELF function in
transcription may not be restricted to Pol II pausing during early
elongation. How a Pol II-pausing factor influences transcription
initiation remains to be elucidated. Notably, a recent study using9–85, April 10, 2014 ª2014 The Authors 83
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Transcription Initiation Complex
(A) ChIP of total Pol II at TSS.
(B) Ratio of total Pol II ChIP at TSS over gene body.
(C) TFIIB ChIP at TSS.
(D) RXRa ChIP at PPARa binding sites (PBS).
(E) Histone H3 ChIP at TSS (n = 3).
(F) A proposed role of NELF in controlling chromatin
occupancy of the transcription initiation complex.computational simulation suggests a complex and reciprocal
influence between recruitment and movement of Pol II on the
ultimate transcriptional efficiency (Ehrensberger et al., 2013).
We propose that NELF acts to forestall precocious release
of the paused transcription apparatus, which in turn ensures
efficient and sustained occupancy of transcription initiation
factors for the subsequent rounds of transcription at the en-
ergy-metabolism-related genes in myocardium (Figure 4F).
Thus, transcriptional control at the initiation and early elongation
steps can be bidirectional for the metabolism-related genes in
cardiomyocytes.
Given the essential role of NELF-B in early embryogenesis, it is
somewhat surprising that NELF-B deletion in adult mice did not
lead to acute mortality. The chronic deterioration of the cardiac
function of the KO mice strongly suggests that NELF is particu-84 Cell Reports 7, 79–85, April 10, 2014 ª2014 The Authorslarly important to support transcriptional
program that meets the heightened needs
of energy production in the myocardium.
Deregulation of transcriptional elongation
has been previously implicated in patho-
logic cardiac hypertrophy (Anand et al.,
2013; Espinoza-Derout et al., 2009; Sano
et al., 2002). The link between energy
metabolism and NELF raises the distinct
possibility that pharmacological agents
aimed at enhancing Pol II pausing may
overcome stress-triggered metabolic defi-
ciency and cardiac abnormality in humans.
EXPERIMENTAL PROCEDURES
Animals
NELF-B flox/flox mice (Amleh et al., 2009) were
backcrossed to C57BL/6J inbred mice for over
ten generations. The CAG-Cre-ER transgenic mice
and a-MHC-MerCreMer transgenic mice were pur-
chased from the Jackson Laboratory.
Echocardiography
Transthoracic echocardiography was conducted
using a Vevo 770 system (VisualSonics) with a
30 MHz image transducer to assess function of
the LV. The same cohort of mice at weeks 8, 16,
24, and 32 was used for serial echocardiography
with or without dobutamine administration.
Metabolomic Profiling
HPLC-ESI-MS/MS analyses of the LV samples
were conducted on a Thermo Fisher Q Exactive
mass spectrometer with online separation usingeither a Thermo Fisher/Dionex RSLC nano HPLC (for lipids) or an Ultimate
3000 HPLC (for polar metabolites).
Statistical Analysis
For analysis of the echocardiography results, a linear regression model was
fitted to the fractional shortening data with age, genotype, sex, and dobut-
amine (i.e., whether themeasurement was taken before or after administration)
as the explanatory variables. Random animal effect was included in the model
along with a random animal-specific component to age-related change. Bidi-
rectional stepwise model selection was performed, yielding the final model
for fractional shortening presented in Figure 1G. Multiple group comparisons
were performed using the one-way ANOVA, followed by the Student-
Newman-Keuls posttest (when the Bartlett variation test passed), or using
the nonparametric Kruskal-Wallis test followed by Dunn posttest (when the
Bartlett variation test did not pass). Statistical analysis of all the other experi-
mental data in the current study was performed by a Student’s t test. p values
of less than 0.05 were considered statistically significant.
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